Latest news
Annexon Announces Positive Clinical Outcomes from GBS FORWARD Study on Tanruprubart - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 17:44:27 GMTABLi Therapeutics Announces Outcomes from its Parkinson’s-related Biomarker Study Demonstrating Modification of Human Disease with Risvodetinib - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:05:00 GMTReplimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma - The Manila TimesThe Manila Times · Thu, 30 Jul 2026 22:36:54 GMTInvestigational Oral PAH Drug Cuts Clinical Worsening Risk 55% - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT